X @Bloomberg
Bloombergยท2025-07-09 10:44Acquisition - Merck & Co agrees to acquire Verona Pharma for approximately $10 billion [1] Strategic Rationale - The acquisition aims to mitigate the anticipated patent expiration of Merck's best-selling cancer drug [1]